Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Pharmacology and clinical efficacy of cholinesterase inhibitors
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacology and clinical efficacy of cholinesterase inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacology
100%
Acetylcholinesterase Inhibitors (AChEI)
100%
Clinical Efficacy
100%
Alzheimer's Disease
57%
Donepezil
42%
Tacrine
42%
Metrifonate
42%
Adverse Effects
28%
Clinical Trials
14%
Once-daily
14%
Rivastigmine
14%
Cholinesterase Inhibition
14%
Interview-based
14%
Metabolic Pathway
14%
Cognitive Deficits
14%
Drug Efficacy
14%
Activities of Daily Living
14%
Hepatotoxicity
14%
Behavior Problems
14%
Pharmacokinetic Differences
14%
Alzheimer's Disease Assessment Scale
14%
Clinician Interviews
14%
Caregiver Input
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cholinesterase Inhibitor
100%
Alzheimer's Disease
71%
Donepezil
42%
Tacrine
42%
Metrifonate
42%
Adverse Event
28%
Rivastigmine
14%
Cholinesterase
14%
Clinical Trial
14%
Cognitive Defect
14%
Hepatotoxicity
14%
Problem Behavior
14%
Pharmacokinetics
14%